Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XTR004 PET MPI for Detecting Restrictive Stenosis in CAD
NCT07439133Phase 3Recruiting
- Sponsor
- Sinotau Pharmaceutical Group
- Start
- Nov 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 18F-FMPP in coronary artery disease (CAD), sponsored by Sinotau Pharmaceutical Group. Started Nov 2025; status: recruiting.
02
Drugs
18F-FMPP
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07439133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07439133.